PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 376974

Clearance tests of liver function.

D H Brody·L Leichter
View original source ↗Export metadata ↓

Abstract

Measurement of the clearance of substances removed from the circulation primarily by the liver, which depends on the uptake, storage, and excretory capacity of the liver, provides the most sensitive, specific, and reliable test for hepatic function. Since serum enzymes and other tests of liver function do not permit detection of early phase injury or provide information on progress, and since the use of sulfobromophthalein has been discontinued because of occasional fatal reactions, substitutes are necessary. Clearance of indocyanine green, bile acid, and exogenous metabolites such as galactose, protein, and aminopyrine are reviewed.

Explore related subjects

AminopyrineBile Acids and SaltsHumansIndocyanine GreenKineticsLiverLiver DiseasesLiver Function TestsRadioimmunoassayJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D H Brody, L Leichter. 1979. Clearance tests of liver function.. https://doi.org/10.1016/s0025-7125(16)31692-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Mediation of the behavioral, endocrine and thermoregulatory actions of ghrelin.

The action of ghrelin on telemetrically recorded motor activity and the transmission of the effects of this neuropeptide on spontaneous and exploratory motor activity and some related endocrine and homeostatic parameters were investigated. Different doses (0.5-5 microg) of ghrelin administered intracerebroventricularly caused significant increases in both square crossing and rearing activity in the "open-field" apparatus, while only the dose of 5 microg evoked a significant increase in the spontaneous locomotor activity recorded by telemetry. Ghrelin also induced significant increases in corticosterone release and core temperature. To determine the transmission of these neuroendocrine actions, the rats were pretreated with different antagonists, such as a corticotropin-releasing hormone (CRH) antagonist (alpha-helical CRH(9-41)), the nitric oxide synthase inhibitor Nomega-nitro-L-arginine-methyl ester (L-NAME), haloperidol, cyproheptadine or the cyclooxygenase inhibitor noraminophenazone (NAP). The open-field and biotelemetric observations revealed that the motor responses were diminished by pretreatment with the CRH antagonist and haloperidol. In the case of HPA (hypothalamic pituitary adrenal) activation, only cyproheptadine pretreatment proved effective; haloperidol and L-NAME did not modify the corticosterone response. NAP had only a transient, while cyproheptadine elicited a more permanent impact on the hyperthermic response evoked by ghrelin; the other antagonists proved to be ineffective. The present data suggest that both CRH release and dopaminergic transmission may be involved in the ghrelin-evoked behavioral responses. On the other hand, ghrelin appears to have an impact on the HPA response via a serotonergic pathway and on the hyperthermic response via a cyclooxygenase and a serotonergic pathway.

Aminopyrine↗